-
Michael J. Fox Foundation and Sanofi Launch Clinical Trial for Drug to Treat Parkinson’s-Related Cognitive Decline
January 21, 2013
… Parkinson’s in different ways.” Researchers believe that multiple systems are at work in cognitive dysfunction in PD, including the dopaminergic system known for its role in the motor symptoms of the …
-
John Daniel O'Sullivan, MD
… in movement disorders research. He has led and coordinated multiple clinical trials in Parkinson’s disease and has over … therapy in some patients. Dr. O’Sullivan currently oversees multiple research projects on non-motor symptoms in …
-
Martin E. Sanders, MD
… research, patient care, senior officer positions at multiple companies, venture capital partnership, and membership on multiple for-profit and non-profit boards. He is a …
-
Warren D. Hirst, PhD
… α-synuclein antibody, which is in Phase 2 trials, using multiple modalities, from antibodies and antisense … grant review committees, and as an ad-hoc reviewer for multiple journals including Neuron and PNAS. Warren has received multiple grants in addition to serving as a reviewer and …
-
Pre-clinical Development of a Parkinson's Disease Therapy Using a Glucagon-Like Peptide (GLP)-1 Receptor Agonist
… neurochemical, and histopathological deficits in multiple rodent models of PD. Exendin-4 has the potential to … A manuscript describing the effects of exendin-4 on multiple therapeutic endpoints, including neurobehavioral … in vivo, it has been shown to have robust efficacy in multiple rodent models of PD, and it is already an …
-
Lorene Nelson, PhD, MS
… disease, amyotrophic lateral sclerosis (ALS) and multiple sclerosis. The primary objectives of Dr. Nelson’s … Dr. Nelson is a scientific advisor to the National Multiple Sclerosis Society and the Amyotrophic Lateral …